Cannabis is one of the most studied plants of the decade. Treatment-resistant epilepsy, chronic pain, spasticity, anxiety, insomnia, effects on cancer or Parkinson's patients: scientific publications are multiplying, clinical trials are piling up, and regulators are moving forward cautiously.
Since 2015, Newsweed has been tracking all the news at the intersection of cannabis and health: study results, market launches (Sativex, Epidiolex), prescription debates, patient testimonials and scientific controversies. A rigorous, French-language watch for patients, caregivers and the curious.
Massachusetts voters will decide this coming November whether to partially roll back the legalization of cannabis in the state, as a repeal initiative has gathered enough...
While U.S. federal authorities have reclassified some forms of cannabis as a Schedule III controlled substance, recognizing its medical use and, to a lesser extent...
On September 28 and 29, 2026, Paris will host the third edition of Science in the City International, a symposium organized by the Medical Resource Association that will bring together...
More than a year after voters in the Cayman Islands voted in favor of decriminalizing cannabis, the Legislative Reform Commission (LRC)...
After years of delays, France has taken another step toward establishing a permanent framework for medical cannabis. The decree...
More than seven years after cannabis was legalized for adult use, Guam has officially issued its first cannabis operating license. The license was...
Four months after the Council of Ministers of Bosnia and Herzegovina approved the legalization of medical cannabis, authorities are now working to develop the regulatory framework...
The medical cannabis sector in the United Kingdom continues to expand, with the number of patients expected to exceed 140,000 by the end of 2026. According to the latest UK...
The canton of St. Gallen has officially launched one of Switzerland’s largest cannabis pilot projects, allowing up to 5,000 adult users to legally access...
Nebraska authorities have just authorized the first medical cannabis production facility to begin growing plants. At a meeting of the Commission...
Uruguay was the first country in the world to legally regulate the entire cannabis industry. Yet, ten years later, medical cannabis still hasn't...
As South Carolina prepares to elect its next governor, the debate over medical cannabis in the state is once again coming to the forefront...
The French Minister of Health confirmed to Agence France-Presse (AFP) that the regulations—which have been expected to be published for two years and which...
Four years after the launch of the national pilot program, a study commissioned by the ANSM finally provides concrete data on the effect of medical cannabis on treatments...
Just a few weeks ago, the future of cannabis in Virginia seemed to be at a standstill. In May 2026, Governor Abigail Spanberger had vetoed two...
Canadian cannabis producer Canopy Growth announced a significant improvement in its financial results for the fourth quarter of fiscal year 2026, thanks to strong...
The first medical cannabis prescriptions have been issued in Ukraine, marking the start of a program for people suffering from serious and chronic conditions, including...
An urgent circular from the General Directorate of Health, dated June 11, 2026, sounds the alarm about a significant increase in cases of poisoning...
Nearly eight years after the Constitutional Court’s ruling authorizing the cultivation and possession of cannabis for personal use, South Africa is struggling...
German biopharmaceutical company Vertanical, which we reported on last Friday after receiving «breakthrough therapy» status from the FDA for its treatment...
